COX-2 Patents

I applaud your continued efforts to bring business and legal issues to the attention of the scientific community.1 However, there are a few points that I wish to make. First, the subhead "Awarding of patent may only reflect who filed first," while titillating, is clearly legally incorrect under U.S. patent law. In the United States the first to invent any new and useful article of manufacture or method is the true inventor and entitled to a patent, if the inventor satisfies the disclosure, descr

Written byMark Chao
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I applaud your continued efforts to bring business and legal issues to the attention of the scientific community.1 However, there are a few points that I wish to make. First, the subhead "Awarding of patent may only reflect who filed first," while titillating, is clearly legally incorrect under U.S. patent law. In the United States the first to invent any new and useful article of manufacture or method is the true inventor and entitled to a patent, if the inventor satisfies the disclosure, description, and other requirements for a patent under U.S. law. This is in contrast to the rest of the world where the first to file, regardless of their being the actual first to invent anything, is usually granted the patent.

Recent attempts have been made to alter U.S. law from a first to invent system to the first to file system; however, many legal, cultural, and policy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies